Allarity Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Allarity Therapeutics, Inc. reported Earnings Per Share Diluted of $10.26 (loss) per share for the year ending 2023.

  • Allarity Therapeutics, Inc. showed an increase of +99.7% in Earnings Per Share Diluted from 2022 to 2023.
  • This data is from Allarity Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 8, 2024.
  • XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2021 to 2023), Allarity Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 144.9%.
  • Historical annual values: Fiscal year 2023: $10.26 (loss) per share | Fiscal year 2022: $3,093.42 (loss) per share | Fiscal year 2021: $4.19 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: